Related Experiment Video
Updated: Feb 7, 2026

12:29
mRNA Interactome Capture from Plant Protoplasts
Published on: July 28, 2017
9.6K
Targeting the integrin interactome in human disease.
Miguel Vicente-Manzanares1, Francisco Sánchez-Madrid2
1Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer, CIC-IBMCC (CSIC-Universidad de Salamanca), 37007 Salamanca, Spain.
Current Opinion in Cell Biology
|July 15, 2018
Summary
Targeting integrins successfully treats inflammatory diseases by modulating cell adhesion. However, cancer treatment targeting integrins has shown limited success due to cancer cell adaptability.
Area of Science:
- Cellular Biology
- Immunology
- Oncology
Background:
- Integrins are key cell adhesion receptors mediating cell-matrix and cell-cell interactions.
- Microenvironment signals fine-tune integrin function and interactions with other proteins.
- Integrins play critical roles in inflammatory diseases and cancer pathogenesis.
Purpose of the Study:
- To review the therapeutic efficacy of targeting integrins in inflammatory diseases versus cancer.
- To elucidate the reasons behind the differential success of integrin-targeted therapies.
Main Methods:
- Review of clinical trial data and scientific literature on integrin-targeted therapies.
- Analysis of integrin biology in the context of inflammation and cancer progression.
Main Results:
- Integrin-targeting agents have proven effective in managing autoimmune and inflammatory conditions.
- Therapeutic strategies targeting integrins show limited efficacy in treating various cancers.
- Cancer cell plasticity and adaptability contribute to the failure of integrin-targeted anti-cancer therapies.
Conclusions:
- Integrin targeting is a validated strategy for controlling inflammatory diseases.
- The clinical success of integrin inhibition in cancer is hampered by tumor cell adaptability.
- Further research is needed to overcome resistance mechanisms for effective integrin-based cancer therapy.
Related Concept Videos
Integrins
5.5K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
Activation of Integrins
5.1K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.1K
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K

